This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
General Information
Mouse: C57BL/6 x 129/Sv
Mice with a germ-line deletion of exons 4-7 of the PINK1 gene leading to non-sense mediated decay of truncated mRNA and no detectable expression of the PINK1 protein.
Corresponding human genotype: Autosomal recessive mutation in the PINK1 gene causing a loss-of-function of the protein and leading to early-onset Parkinson’s disease (PARK6).
Mutated gene: PINK1
References: Kitada 2007
Neurodegeneration
- 2-9 months: normal morphology and no loss of TH-positive neurons are observed in the SN
Dopamine Homeostasis
- 2-9 months: no changes in the levels of dopamine and dopamine metabolites are observed in the striatum.
Inclusions
- Not reported
Motor Behaviours
- Not reported
Response to dopaminergic treatment
- Not reported
Non motor Behaviours
- Not reported
Electrophysiology
- 2-9 months: amperometric recordings indicate a significant decrease in electrical stimulation-evoked dopamine overflow which is due to reduced release of dopamine. This reflects a functional defect but not a structural defect as DNA synthesis and the number of TH-neurons is not affected.
- 2-9 months: Reduction of LTP and LTD is detected at cortical synapses; no alterations in synaptic plasticity are observed at hippocampal glutamatergic synapses.
Neuroinflammation
- Not reported
